Avammune Therapeutics Secures $12 Million in Series A Funding to Revolutionize Cancer Treatment with Innovative Immunotherapies

Avammune Therapeutics raises $12 million in Series A funding to advance its innovative small molecule immunotherapies for cancer and autoimmune disorders, with promising preclinica...